| Name | 3,6-Dichloro-4-ethylpyridazine |
|---|---|
| Synonyms |
Pyridazine, 3,6-dichloro-4-ethyl-
Pyridazine,3,6-dichloro-4-ethyl 3,6-Dichloro-4ethylpyridazine 3,6-Dichloro-4-ethylpyridazine |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 289.8±35.0 °C at 760 mmHg |
| Molecular Formula | C6H6Cl2N2 |
| Molecular Weight | 177.031 |
| Flash Point | 156.7±11.5 °C |
| Exact Mass | 175.990799 |
| PSA | 25.78000 |
| LogP | 1.89 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.543 |
| HS Code | 2933990090 |
|---|
|
~52%
107228-54-6 |
| Literature: Bristol-Myers Squibb Company Patent: US2007/78136 A1, 2007 ; Location in patent: Page/Page column 70-71 ; US 20070078136 A1 |
|
~%
107228-54-6 |
| Literature: SANOFI-AVENTIS Patent: US2011/34452 A1, 2011 ; Location in patent: Page/Page column 34 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |